Uptake of Biogen's breakthrough Alzheimer's drug, Leqembi, appears to be picking up, with roughly $40 million in sales for the quarter. Read more...
Fake shopping sprees and ‘happiness insurance’: The latest fintech apps reveal our financial anxieties






